Therefore, the low prevalence of anti-PLA2R Ab at the end of follow-up in this study demonstrated that anti-PLA2R Ab is a prognostic biomarker for primary MGN as against UPCr Index level, which showed fewer subjects achieving remission at the end of follow-up. The gene discussed is PLA2R1; the disease is idiopathic membranous glomerulonephritis.